Edison, NJ, United States of America

Robert G Shorr

USPTO Granted Patents = 34 

 


Average Co-Inventor Count = 2.6

ph-index = 16

Forward Citations = 782(Granted Patents)


Location History:

  • Overbrook Hills, PA (US) (1991 - 1993)
  • Wynnewood, PA (US) (1994 - 1998)
  • Edison, NJ (US) (1993 - 2022)

Company Filing History:


Years Active: 1991-2022

Loading Chart...
Loading Chart...
Loading Chart...
34 patents (USPTO):

Title: The Innovations of Robert G Shorr: A Pioneer in Cancer Treatment and Metabolic Disorders

Introduction:

Robert G Shorr, a prolific inventor based in Edison, NJ, has made significant contributions to the fields of cancer treatment and metabolic disorders. With an impressive portfolio of 31 patents, his groundbreaking work has revolutionized the way we approach the treatment of metastatic cancer and metabolic dysfunctions.

Latest Patents:

Shorr's latest patents focus on developing compositions for the treatment of metastatic cancer and metabolic disorders. His inventions include formulations containing glycerides, fatty acids, and their derivatives, combined with cancer metabolism disruptors and immune response modulators. These compositions have shown promising results in killing circulating cancer cells responsible for metastasis and preventing cancer relapse. Additionally, Shorr has introduced thiol-containing alkyl fatty acid compounds for the treatment of pre-diabetes, diabetes, and metabolic syndrome, offering controlled bioavailability and effective therapeutic options.

Career Highlights:

Throughout his career, Shorr has worked with esteemed companies such as Enzon, Inc., where he honed his expertise in drug development and biotechnology. His innovative approach to addressing unmet medical needs has garnered recognition within the industry, positioning him as a trusted authority in the field of oncology and metabolic disorders. Shorr's dedication to improving patient outcomes underscores his commitment to advancing healthcare through cutting-edge research and development.

Collaborations:

Shorr has collaborated with accomplished professionals in the industry, including Mike A Clark and Robert J Rodriguez. These partnerships have led to synergistic efforts in advancing novel therapies and treatment modalities, leveraging their collective expertise to address complex medical challenges. By fostering collaborations with like-minded innovators, Shorr has been able to broaden the impact of his inventions and contribute to the advancement of medical science.

Conclusion:

Robert G Shorr's pioneering work in cancer treatment and metabolic disorders exemplifies a dedication to innovation and excellence in healthcare. His steadfast commitment to improving patient care and outcomes underscores the transformative potential of his inventions. As he continues to push the boundaries of medical research, Shorr's contributions will undoubtedly shape the future of oncology and metabolic therapeutics, offering hope to patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…